Peregrine Pharma (NASDAQ: PPHM) announced the publication of a peer-reviewed manuscript related to preclinical research demonstrating that the company's lead ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE